0 followers
Azafaros is developing new treatment options to help patients with rare metabolic disorders. Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with disease-modify... Read more
Stefano Portolano
Synthekine
3 followers
Caribou Biosciences
2 followers
Vera Therapeutics
2 followers
Neogene Therapeutics
2 followers
Kyverna Therapeutics
7 followers
Day One Biopharmaceuticals
1 follower
Isotopen Technologien München
1 follower
Aura Biosciences
1 follower
CG Oncology
1 follower
Aviceda Therapeutics
1 follower
Foresight Diagnostics
1 follower
Explore companies